CORCEPT THERAPEUTICS INC Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
CORCEPT THERAPEUTICS INC (CORT) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$263.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-03.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2020-11-03
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2020-09-30 was -$263.00K.
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2020-06-30 was $530.00K, a 133.48% increase year-over-year.
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2020-03-31 was $49.00K, a 70.12% decline year-over-year.
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2019-09-30 was -$7.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month |
|---|---|---|---|
| 2020-09-30 | -$263.00K 10-Q · filed 2020-11-03 | $267.00K derived: sum of 2 quarters · filed 2020-11-03 | $316.00K derived: sum of 3 quarters · filed 2020-11-03 |
| 2020-06-30 | $530.00K 10-Q · filed 2020-11-03 | $579.00K derived: sum of 2 quarters · filed 2020-11-03 | |
| 2020-03-31 | $49.00K 10-Q · filed 2020-11-03 | ||
| 2019-09-30 | -$7.00K 10-Q · filed 2020-11-03 | $220.00K derived: sum of 2 quarters · filed 2020-11-03 | $384.00K derived: sum of 3 quarters · filed 2020-11-03 |
| 2019-06-30 | $227.00K 10-Q · filed 2020-11-03 | $391.00K derived: sum of 2 quarters · filed 2020-11-03 | |
| 2019-03-31 | $164.00K 10-Q · filed 2020-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |